key: cord-0929557-xcrd2oj4
authors: Corradetti, Giulia; Corvi, Federico; Nguyen, Tieu Vy; Sadda, SriniVas R.
title: Management of neovascular age-related macular degeneration during the COVID-19 pandemia
date: 2020-05-29
journal: Ophthalmology. Retina
DOI: 10.1016/j.oret.2020.05.015
sha: 2197372dc75a5bd19bd45adb58823556a02af5d0
doc_id: 929557
cord_uid: xcrd2oj4

nan

seeing subjects with a severe atypical respiratory illness, anticipating the global health crisis by more than 37 three weeks. 1 practice situation, based on local and regional conditions and rules, public health authorities communications 63 and on institutional policies, given the large variations in prevalence of COVID-19 across the United States.

The requirement for ophthalmologists to be physically close to the patients' eyes during the ophthalmological 65 evaluation has led to a perception that there may be a higher risk of infection, a problem exacerbated by a 66 shortage of PPE and high patient volumes in clinic. However, retina represents a particular specialty in 67 ophthalmology that is called to manage a significant number of conditions, such as proliferative diabetic 

Procedures have also been implemented to manage potential shortages in personal protective equipment.

Each staff member and physician is made available at least one new surgical mask per day. Ultraviolet 121 sterilization devices have also been procured and used to sterilize surgical masks as needed. 13 Gloves are 122 also used when contact with the patient or the patient's eyes are required, as tears are known to harbor the 123 virus. As COVID-19 is a respiratory coronavirus, transmission is believed to be primarily through respiratory 

Adherence to these rules and principles is essential in order to create a safe environment for our patients, 141 staff, and physicians. Although we consider every individual as potentially infected, the strategy that we 142 employ also utilizes a risk stratification process to ensure that we provide as safe an environment as implementing more stringent protective gear (e.g. N95 respirators) even while seeing low COVID risk 153 patients. As the pandemic crisis continues to evolve, we expect that procedures and protocols will also 154 evolve in parallel. We also recognize that while these protocols work in our practice environment, they may specialists, but may need to be considered as more data becomes available.

In conclusion, the COVID-19 pandemic has dramatically impacted the practice of medicine in all specialties 161 and has profoundly impacted public health. As retina specialists we continue to strive to provide the best 

Ophthalmologists Are More Than Eye Doctors

Situation Reportd -51 WHOC disease 2019 (COVID19

Remdesivir in the treatment of Coronavirus Disease 2019 (COVID-19): A simplified 196 summary

An Update on Current Therapeutic Drugs Treating COVID-19

Clinical features of COVID-19 in elderly patients: A comparison with 201 young and middle-aged patients

Taking care of older patients with cancer in the context of 203

COVID-19 pandemic. The Lancet Oncology

A view of the current and future role of 205 optical coherence tomography in the management of age-related macular degeneration

Evolution of Intravitreal Therapy for Retinal Diseases-From CMV to CNV: The LXXIV 208

Development of Anti-VEGF Therapies for Intraocular Use: A Guide for 211

Anti-vascular endothelial growth 213 factor for neovascular age-related macular degeneration. Cochrane Database of Systematic 214 Reviews

Challenges and solutions for addressing critical shortage of supply chain for